XML 56 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation (Tables)
 12 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of allocation of share-based compensation costs by plan The following is a summary of stock-based compensation expense related to stock options and restricted stock awards for the fiscal years ended 2022, 2021 and 2020, respectively.
Fiscal Year Ended September 30,
in thousands202220212020
Stock options expense$1 $25 $133 
Restricted stock awards expense8,477 12,142 9,903 
Stock-based compensation expense$8,478 $12,167 $10,036 
Schedule of assumptions for stock option activity We used the following valuation assumptions for stock options granted for the periods presented:
Fiscal Year Ended September 30,
20222020
Expected life of options5.7 years5.7 years
Expected volatility55.02 %51.52 %
Expected dividends— — 
Weighted-average risk-free interest rate1.88 %0.43 %
Weighted-average fair value$8.54 $4.99 
For the Company and each member of the peer group, the
following inputs were used, as applicable, in the Monte Carlo valuation model to determine the fair value as of the grant date
for performance-based restricted stock granted in each of the fiscal years ended.
Fiscal Year Ended September 30,
202220212020
Expected volatility range
41.0% - 89.0%
26.1% - 67.0%
21.2% - 54.8%
Risk-free interest rate0.81 %0.23 %1.61 %
Dividend yield— — — 
Grant-date stock price range
$21.40 - $142.99
$14.07 - $4,318.03
$15.62 - $3,595.17
Schedule of stock options activity
A summary of stock option activity for the periods presented is as follows:
 202220212020
 SharesWeighted-
Average
Exercise
Price		SharesWeighted-
Average
Exercise
Price		SharesWeighted-
Average
Exercise
Price
Outstanding at beginning of period114,259 $17.89 392,465 $15.47 523,754 $14.34 
Granted236 16.58 — — 950 10.67 
Exercised(988)11.32 (278,206)14.48 (128,921)11.01 
Expired(86,000)19.11 — — — — 
Forfeited— — — — (3,318)9.55 
Outstanding at end of period27,507 $14.31 114,259 $17.89 392,465 $15.47 
Exercisable at end of period27,271 $14.29 113,309 $17.95 354,796 $15.90 
Schedule of stock options exercised and vested
Information pertaining to the intrinsic value of options exercised and the fair market value of options that vested is below:
Fiscal Year Ended September 30,
in thousands202220212020
Intrinsic value of options exercised$6 $1,402 $587 
Fair market value of options vested$5 $173 $144 
Schedule of nonvested stock awards and performance shares
Activity relating to all restricted stock awards for the periods presented is as follows:
Year Ended September 30, 2022
 
Performance-Based(a)
Time-BasedTotal
 SharesWeighted-
Average
Grant
Date Fair
Value		SharesWeighted-
Average
Grant
Date Fair
Value		SharesWeighted-
Average
Grant
Date Fair
Value
Beginning of period738,155 $13.45 486,574 $13.79 1,224,729 $13.59 
Granted269,617 18.98 246,844 21.40 516,461 20.14 
Vested(552,417)10.50 (286,182)13.21 (838,599)11.42 
Forfeited(19,209)17.27 (35,194)16.49 (54,403)16.77 
End of period436,146 $17.76 412,042 $18.52 848,188 $18.13 
(a) Grant and vesting activity during the year ended September 30, 2022 include 177,759 shares that were issued above target based on performance level achieved under performance-based restricted stock vesting in the current period.

Year Ended September 30, 2021
 
Performance-Based(a)
Time-BasedTotal
 SharesWeighted-
Average
Grant
Date Fair
Value		SharesWeighted-
Average
Grant
Date Fair
Value		SharesWeighted-
Average
Grant
Date Fair
Value
Beginning of period796,024 $14.71 610,130 $13.85 1,406,154 $14.34 
Granted164,296 17.90 251,788 14.21 416,084 15.67 
Vested (222,165)22.40 (346,856)14.36 (569,021)17.50 
Forfeited— — (28,488)11.77 (28,488)11.77 
End of period738,155 $13.45 486,574 $13.79 1,224,729 $13.59 
(a) Grant and vesting activity during the year ended September 30, 2021 include 60,930 shares that were issued above target based on performance level achieved under performance-based restricted stock vesting in the current period.

Year Ended September 30, 2020
 Performance-BasedTime-BasedTotal
 SharesWeighted-
Average
Grant
Date Fair
Value		SharesWeighted-
Average
Grant
Date Fair
Value		SharesWeighted-
Average
Grant
Date Fair
Value
Beginning of period778,814 $13.60 611,607 $12.11 1,390,421 $16.53 
Granted260,131 16.98 327,571 15.29 587,702 16.04 
Vested(242,921)13.60 (302,255)11.89 (545,176)12.65 
Forfeited— — (26,793)13.79 (26,793)13.79 
End of period796,024 $14.71 610,130 $13.85 1,406,154 $14.34